Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze PTGX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate PTGX investment potential.

What is PTGX stock price today?

Get real-time PTGX stock price, historical data, and price charts on Financhill. Track PTGX performance with our advanced analysis tools.

Is PTGX a good investment?

Evaluate PTGX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy PTGX stock?

To buy PTGX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of PTGX?

View detailed market capitalization data and company valuation metrics for PTGX on our comprehensive analysis page.

What is the P/E ratio of PTGX?

Use our fundamental analysis tools to view PTGX P/E ratio and compare valuation metrics with industry peers.

What are PTGX earnings?

View PTGX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Protagonist Therapeutics, Inc. Stock Predictions

$10K Investment in Nvidia Could've Made $2.5M

*DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

PTGX
Protagonist Therapeutics, Inc.

Last Price:

$84.56

Seasonality Move:

9.35%

7 Day Trial

ALL ACCESS PASS

$ 7

The Next AI Boom Won't Be Chips. It'll Be Software-And This Startup Is Leading It.

Protagonist Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Protagonist Therapeutics, Inc. has on average historically risen by 45.3% based on the past 9 years of stock performance.
Protagonist Therapeutics, Inc. has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Is Protagonist Therapeutics, Inc. Stock Undervalued?

The current Protagonist Therapeutics, Inc. [PTGX] share price is $84.61. The Score for PTGX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Protagonist Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Protagonist Therapeutics, Inc. has on average historically risen by 45.3% based on the past 9 years of stock performance.

Protagonist Therapeutics, Inc. Stock Rating

Buy

Protagonist Therapeutics, Inc. (PTGX) is a Buy

Is Protagonist Therapeutics, Inc. overpriced?

Protagonist Therapeutics, Inc. has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Protagonist Therapeutics, Inc. Stock Price History

Is PTGX stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

protagonist-inc.com

52-Week Data

52-Week High:

93.25

52-Week Low:

33.31

Prediction Charts

Market Cap:

5.3B

Price in USD:

84.61

Volume:

755.4K

Beta:

1.94

Technical Analysis

SMA50:

71.05

SMA100:

63.06

SMA200:

54.55

52-Wk Change:

106.16%

Stock Predictions

Is Protagonist Therapeutics, Inc. stock public?

Yes, Protagonist Therapeutics, Inc. is a publicly traded company.
What is the Protagonist Therapeutics, Inc. stock quote today?

The Protagonist Therapeutics, Inc. stock price is 84.61 USD today.
How to buy Protagonist Therapeutics, Inc. stock online?

You can buy Protagonist Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Oct-28	75.06	78.51	78.78	74.80
Oct-29	78.06	76.69	79.00	76.49
Oct-30	77.21	77.85	78.74	76.75
Oct-31	77.53	78.62	79.01	76.66
Nov-3	78.62	75.95	80.43	75.54
Nov-4	75.44	76.50	78.01	75.44
Nov-5	76.50	77.88	78.12	75.55
Nov-6	77.07	79.78	79.92	77.00
Nov-7	80.12	79.54	80.75	76.70
Nov-10	80.58	83.23	84.84	79.56
Nov-11	83.52	85.56	86.00	83.00
Nov-12	85.41	84.85	86.90	84.50
Nov-13	84.84	83.24	86.02	83.17
Nov-14	82.18	84.61	85.90	82.06

Protagonist Therapeutics, Inc. Earnings

Protagonist Therapeutics, Inc. Earnings Report: Per Share Protagonist Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Protagonist Therapeutics, Inc. Forecast Revenue Growth

Protagonist Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Protagonist Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $1.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.50 per share, and an increase next year of $2.19 per share.

* Protagonist Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.